annual EBIT:
-$139.59M-$87.75M(-169.28%)Summary
- As of today (August 31, 2025), VRNA annual earnings before interest & taxes is -$139.59 million, with the most recent change of -$87.75 million (-169.28%) on December 31, 2024.
- During the last 3 years, VRNA annual EBIT has fallen by -$84.34 million (-152.66%).
- VRNA annual EBIT is now -1163125.00% below its all-time high of -$12.00 thousand, reached on December 31, 2005.
Performance
VRNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$13.46M+$23.82M(+229.99%)Summary
- As of today (August 31, 2025), VRNA quarterly earnings before interest & taxes is $13.46 million, with the most recent change of +$23.82 million (+229.99%) on June 1, 2025.
- Over the past year, VRNA quarterly EBIT has increased by +$81.96 million (+119.65%).
- VRNA quarterly EBIT is now at all-time high.
Performance
VRNA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$56.15M+$81.96M(+59.35%)Summary
- As of today (August 31, 2025), VRNA TTM earnings before interest & taxes is -$56.15 million, with the most recent change of +$81.96 million (+59.35%) on June 1, 2025.
- Over the past year, VRNA TTM EBIT has increased by +$75.01 million (+57.19%).
- VRNA TTM EBIT is now -4447.07% below its all-time high of -$1.23 million, reached on June 30, 2016.
Performance
VRNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VRNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -169.3% | +119.7% | +57.2% |
| 3 y3 years | -152.7% | +166.2% | +16.5% |
| 5 y5 years | -244.8% | +222.3% | -7.7% |
VRNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -169.3% | at low | at high | +119.7% | at high | +64.0% |
| 5 y | 5-year | -244.8% | at low | at high | +119.7% | -25.1% | +64.0% |
| alltime | all time | <-9999.0% | at low | at high | +119.7% | -4447.1% | +64.0% |
VRNA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $13.46M(-230.0%) | -$56.15M(-59.3%) |
| Mar 2025 | - | -$10.36M(-43.0%) | -$138.11M(-10.9%) |
| Dec 2024 | -$139.59M(+169.3%) | -$18.17M(-55.8%) | -$154.94M(-0.7%) |
| Sep 2024 | - | -$41.08M(-40.0%) | -$156.03M(+19.0%) |
| Jun 2024 | - | -$68.50M(+152.0%) | -$131.16M(+80.5%) |
| Mar 2024 | - | -$27.18M(+41.1%) | -$72.66M(+7.0%) |
| Dec 2023 | -$51.84M(-23.7%) | -$19.26M(+18.8%) | -$67.87M(+6.4%) |
| Sep 2023 | - | -$16.22M(+62.2%) | -$63.78M(+1.9%) |
| Jun 2023 | - | -$10.00M(-55.4%) | -$62.56M(-14.2%) |
| Mar 2023 | - | -$22.40M(+47.7%) | -$72.89M(-3.3%) |
| Dec 2022 | -$67.93M(+23.0%) | -$15.16M(+1.1%) | -$75.41M(-15.0%) |
| Sep 2022 | - | -$15.00M(-26.2%) | -$88.75M(+32.0%) |
| Jun 2022 | - | -$20.33M(-18.4%) | -$67.22M(-10.8%) |
| Mar 2022 | - | -$24.92M(-12.6%) | -$75.39M(+2.7%) |
| Dec 2021 | -$55.25M(-15.0%) | -$28.50M(-536.6%) | -$73.40M(+63.5%) |
| Sep 2021 | - | $6.53M(-122.9%) | -$44.90M(-38.4%) |
| Jun 2021 | - | -$28.49M(+24.2%) | -$72.91M(+31.5%) |
| Mar 2021 | - | -$22.94M(+6.8%) | -$55.43M(-1.8%) |
| Dec 2020 | -$64.97M(+60.5%) | - | - |
| Sep 2020 | - | -$21.48M(+95.1%) | -$56.42M(+8.2%) |
| Jun 2020 | - | -$11.01M(-24.0%) | -$52.13M(-7.9%) |
| Mar 2020 | - | -$14.49M(+53.6%) | -$56.60M(+8.4%) |
| Dec 2019 | -$40.49M | -$9.44M(-45.1%) | -$52.21M(+0.1%) |
| Sep 2019 | - | -$17.19M(+11.0%) | -$52.16M(+19.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$15.48M(+53.2%) | -$43.78M(+21.7%) |
| Mar 2019 | - | -$10.11M(+7.7%) | -$35.99M(+5.6%) |
| Dec 2018 | -$30.49M(-10.2%) | -$9.38M(+6.5%) | -$34.07M(-12.3%) |
| Sep 2018 | - | -$8.81M(+14.7%) | -$38.86M(-4.5%) |
| Jun 2018 | - | -$7.69M(-6.0%) | -$40.68M(-2.5%) |
| Mar 2018 | - | -$8.18M(-42.3%) | -$41.70M(+7.9%) |
| Dec 2017 | -$33.96M(+367.6%) | -$14.18M(+33.4%) | -$38.65M(+57.9%) |
| Sep 2017 | - | -$10.63M(+22.0%) | -$24.47M(+48.5%) |
| Jun 2017 | - | -$8.71M(+70.0%) | -$16.47M(+83.2%) |
| Mar 2017 | - | -$5.13M(<-9900.0%) | -$8.99M(+132.5%) |
| Dec 2016 | -$7.26M(-45.2%) | $0.00(-100.0%) | -$3.87M(0.0%) |
| Sep 2016 | - | -$2.63M(+113.2%) | -$3.87M(+213.2%) |
| Jun 2016 | - | -$1.23M | -$1.23M |
| Dec 2015 | -$13.25M(+124.4%) | - | - |
| Dec 2014 | -$5.90M(+27.1%) | - | - |
| Dec 2013 | -$4.64M(+11.2%) | - | - |
| Dec 2012 | -$4.18M(+45.6%) | - | - |
| Dec 2011 | -$2.87M(-1.2%) | - | - |
| Dec 2010 | -$2.90M(+12.3%) | - | - |
| Dec 2009 | -$2.59M(+19.0%) | - | - |
| Dec 2008 | -$2.17M(-16.0%) | - | - |
| Dec 2007 | -$2.59M(+97.0%) | - | - |
| Dec 2006 | -$1.31M(>+9900.0%) | - | - |
| Dec 2005 | -$12.00K | - | - |
FAQ
- What is Verona Pharma plc annual earnings before interest & taxes?
- What is the all time high annual EBIT for Verona Pharma plc?
- What is Verona Pharma plc annual EBIT year-on-year change?
- What is Verona Pharma plc quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Verona Pharma plc?
- What is Verona Pharma plc quarterly EBIT year-on-year change?
- What is Verona Pharma plc TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Verona Pharma plc?
- What is Verona Pharma plc TTM EBIT year-on-year change?
What is Verona Pharma plc annual earnings before interest & taxes?
The current annual EBIT of VRNA is -$139.59M
What is the all time high annual EBIT for Verona Pharma plc?
Verona Pharma plc all-time high annual earnings before interest & taxes is -$12.00K
What is Verona Pharma plc annual EBIT year-on-year change?
Over the past year, VRNA annual earnings before interest & taxes has changed by -$87.75M (-169.28%)
What is Verona Pharma plc quarterly earnings before interest & taxes?
The current quarterly EBIT of VRNA is $13.46M
What is the all time high quarterly EBIT for Verona Pharma plc?
Verona Pharma plc all-time high quarterly earnings before interest & taxes is $13.46M
What is Verona Pharma plc quarterly EBIT year-on-year change?
Over the past year, VRNA quarterly earnings before interest & taxes has changed by +$81.96M (+119.65%)
What is Verona Pharma plc TTM earnings before interest & taxes?
The current TTM EBIT of VRNA is -$56.15M
What is the all time high TTM EBIT for Verona Pharma plc?
Verona Pharma plc all-time high TTM earnings before interest & taxes is -$1.23M
What is Verona Pharma plc TTM EBIT year-on-year change?
Over the past year, VRNA TTM earnings before interest & taxes has changed by +$75.01M (+57.19%)